{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:00:40Z","timestamp":1788811240549,"version":"build-2803163510"},"reference-count":132,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":1461,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","award":["16OKG02"],"award-info":[{"award-number":["16OKG02"]}],"id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.kint.2017.11.036","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T18:18:08Z","timestamp":1521829088000},"page":"1060-1072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Prevention and treatment of hyperphosphatemia in chronic kidney disease"],"prefix":"10.1016","volume":"93","author":[{"given":"Marc G.","family":"Vervloet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana J.","family":"van Ballegooijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2017.11.036_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/ki.2010.281","article-title":"FGF23 or PTH: which comes first in CKD?","volume":"78","author":"Isakova","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib3","doi-asserted-by":"crossref","first-page":"F285","DOI":"10.1152\/ajprenal.00508.2009","article-title":"Phosphate homeostasis and the renal-gastrointestinal axis","volume":"299","author":"Marks","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2017.11.036_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ki.2008.130","article-title":"Hyperphosphatemia of chronic kidney disease","volume":"74","author":"Hruska","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib5","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/nrneph.2010.121","article-title":"Hereditary disorders of renal phosphate wasting","volume":"6","author":"Alizadeh Naderi","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib6","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/cvr\/cvs240","article-title":"Effects of phosphate on vascular function under normal conditions and influence of the uraemic state","volume":"96","author":"Six","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.kint.2017.11.036_bib7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrneph.2016.164","article-title":"The role of phosphate in kidney disease","volume":"13","author":"Vervloet","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib8","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa062276","article-title":"Normalization of hemoglobin level in patients with chronic kidney disease and anemia","volume":"355","author":"Drueke","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.036_bib9","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2017.11.036_bib10","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ahj.2008.05.016","article-title":"Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) study","volume":"156","author":"Foley","year":"2008","journal-title":"Am Heart J"},{"key":"10.1016\/j.kint.2017.11.036_bib11","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/archinte.167.9.879","article-title":"Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community","volume":"167","author":"Dhingra","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.kint.2017.11.036_bib12","doi-asserted-by":"crossref","first-page":"e001706","DOI":"10.1161\/JAHA.114.001706","article-title":"Joint effect of hypertension and elevated serum phosphorus on the risk of mortality in national health and nutrition examination survey-III","volume":"4","author":"Vart","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.kint.2017.11.036_bib13","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2215\/CJN.00810110","article-title":"Serum phosphate and mortality in patients with chronic kidney disease","volume":"5","author":"Eddington","year":"2010","journal-title":"Clin J Am Soc Nephrol."},{"key":"10.1016\/j.kint.2017.11.036_bib14","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","article-title":"High plasma phosphate as a risk factor for decline in renal function and mortality in predialysis patients","volume":"22","author":"Voormolen","year":"2007","journal-title":"Nephrology Transplant"},{"key":"10.1016\/j.kint.2017.11.036_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/j.ajkd.2005.05.025","article-title":"Relationship of phosphorus and calcium-phosphorus product with mortality in CKD","volume":"46","author":"Menon","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.036_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","article-title":"Serum phosphate levels and mortality risk among people with chronic kidney disease","volume":"16","author":"Kestenbaum","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib17","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.036_bib18","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.2004040275","article-title":"Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study","volume":"16","author":"Slinin","year":"2005","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib19","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/ndt\/gfq304","article-title":"Calcium, phosphorus, PTH and death rates in a large sample of dialysis patients from Latin America. The CORES study","volume":"26","author":"Naves-Diaz","year":"2011","journal-title":"Nephrology Transplant"},{"key":"10.1016\/j.kint.2017.11.036_bib20","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib21","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1681\/ASN.V12102131","article-title":"Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients","volume":"12","author":"Ganesh","year":"2001","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib22","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrology Transplant"},{"key":"10.1016\/j.kint.2017.11.036_bib23","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients","volume":"70","author":"Kalantar\u2013Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00774-011-0343-z","article-title":"Can features of phosphate toxicity appear in normophosphatemia?","volume":"30","author":"Osuka","year":"2012","journal-title":"J\u00a0Bone Miner Metab"},{"key":"10.1016\/j.kint.2017.11.036_bib25","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.2215\/CJN.03860411","article-title":"Kinetic model of phosphorus mobilization during and after short and conventional hemodialysis","volume":"6","author":"Agar","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1681\/ASN.V95859","article-title":"Nocturnal hemodialysis: three-year experience","volume":"9","author":"Pierratos","year":"1998","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib27","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1053\/j.ajkd.2014.02.016","article-title":"Acute hemodynamic response and uremic toxin removal in conventional and extended hemodialysis and hemodiafiltration: a randomized crossover study","volume":"64","author":"Cornelis","year":"2014","journal-title":"Am\u00a0J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.036_bib28","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/kisup.2013.88","article-title":"A\u00a0phosphate-centric paradigm for pathophysiology and therapy of chronic kidney disease (2011)","volume":"3","author":"Kuro","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2017.11.036_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1053\/j.ajkd.2014.04.028","article-title":"Serum phosphorus and mortality in the Third National Health and Nutrition Examination Survey (NHANES III): effect modification by fasting","volume":"64","author":"Chang","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.036_bib30","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00228.2007","article-title":"Phosphate transporters: a tale of two solute carrier families","volume":"293","author":"Virkki","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2017.11.036_bib31","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.RES.0000216409.20863.e7","article-title":"Role of the sodium-dependent phosphate cotransporter, Pit-1, in vascular smooth muscle cell calcification","volume":"98","author":"Li","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2017.11.036_bib32","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/j.ajkd.2015.08.028","article-title":"Metabolic Acidosis of CKD: An Update","volume":"67","author":"Kraut","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.036_bib33","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/ndt\/gfs291","article-title":"Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD?","volume":"27","author":"Kovesdy","year":"2012","journal-title":"Nephrology Transplant"},{"key":"10.1016\/j.kint.2017.11.036_bib34","article-title":"Arterial and Cellular Inflammation in Patients with CKD","author":"Bernelot Moens","year":"2016","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/cvr\/cvw164","article-title":"Intracellular pH steers vascular wall remodelling","volume":"111","author":"Hordijk","year":"2016","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.kint.2017.11.036_bib36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib37","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1681\/ASN.2015111266","article-title":"Chronic hyperphosphatemia and vascular calcification are reduced by stable delivery of soluble klotho","volume":"28","author":"Hum","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib38","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3892\/etm.2016.3996","article-title":"Activation of peroxisome proliferator-activated receptor gamma inhibits vascular calcification by upregulating Klotho","volume":"13","author":"Cheng","year":"2017","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.kint.2017.11.036_bib39","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1038\/sj.ki.5000297","article-title":"Chemical and hormonal determinants of vascular calcification in\u00a0vitro","volume":"69","author":"Lomashvili","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib40","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: key roles for calcium and phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.kint.2017.11.036_bib41","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1097\/01.ASN.0000141960.01035.28","article-title":"Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD","volume":"15","author":"Reynolds","year":"2004","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib42","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1681\/ASN.2009060640","article-title":"Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification","volume":"21","author":"Shroff","year":"2010","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib43","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/ki.2010.390","article-title":"Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in\u00a0vitro","volume":"79","author":"Sage","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1161\/ATVBAHA.108.183384","article-title":"Phosphonoformic acid prevents vascular smooth muscle cell calcification by inhibiting calcium-phosphate deposition","volume":"29","author":"Villa-Bellosta","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.kint.2017.11.036_bib45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1681\/ASN.2013060635","article-title":"Serum calcification propensity predicts all\u2013cause mortality in predialysis CKD","volume":"25","author":"Smith","year":"2014","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib46","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1093\/ndt\/gfr609","article-title":"Phosphorylated fetuin-A-containing calciprotein particles are associated with aortic stiffness and a procalcific milieu in patients with predialysis CKD","volume":"27","author":"Smith","year":"2012","journal-title":"Nephrology Transplant"},{"key":"10.1016\/j.kint.2017.11.036_bib47","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1980.85","article-title":"Renal toxicity of phosphate in rats","volume":"17","author":"Haut","year":"1980","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib48","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1681\/ASN.V1101169","article-title":"Beneficial effects of dietary mineral restriction in dogs with marked reduction of functional renal mass","volume":"1","author":"Brown","year":"1991","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2460\/ajvr.1992.53.01.157","article-title":"Effects of phosphorus\/calcium-restricted and phosphorus\/calcium-replete 32% protein diets in dogs with chronic renal failure","volume":"53","author":"Finco","year":"1992","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.kint.2017.11.036_bib50","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.2460\/ajvr.1982.43.06.1023","article-title":"Effect of dietary phosphorus restriction on the kidneys of cats with reduced renal mass","volume":"43","author":"Ross","year":"1982","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.kint.2017.11.036_bib51","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1172\/JCI106517","article-title":"On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog","volume":"50","author":"Slatopolsky","year":"1971","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2017.11.036_bib52","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.2013.213","article-title":"Phosphate restriction significantly reduces mortality in uremic rats with established vascular calcification","volume":"84","author":"Finch","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib53","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJM197801192980302","article-title":"Preservation of function in experimental renal disease by dietary restriction of phosphate","volume":"298","author":"Ibels","year":"1978","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.036_bib54","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/ki.1986.49","article-title":"Phosphate depletion arrests progression of chronic renal failure independent of protein intake","volume":"29","author":"Lumlertgul","year":"1986","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib55","first-page":"2011","article-title":"Long-term effects of activity and of calcium and phosphorus intake on bones and kidneys of female rats","volume":"113","author":"Bauer","year":"1983","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib56","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI100349","article-title":"Studies of calcium and phosphorus metabolism: XVIII. On temporary fluctuations in the level of calcium and inorganic phosphorus in blood serum of normal individuals","volume":"10","author":"Farquharson","year":"1931","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.kint.2017.11.036_bib57","first-page":"125","article-title":"Effect of high phosphorus intake on calcium and phosphorus metabolism in man","volume":"86","author":"Spencer","year":"1965","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib58","doi-asserted-by":"crossref","first-page":"4264","DOI":"10.1210\/jc.2015-2279","article-title":"Impact of phosphorus-based food additives on bone and mineral metabolism","volume":"100","author":"Gutierrez","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2017.11.036_bib59","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3945\/ajcn.113.073148","article-title":"High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III","volume":"99","author":"Chang","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib60","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/ndt\/gfr367","article-title":"Dietary phosphorus intake and mortality in moderate chronic\u00a0kidney disease: NHANES III","volume":"27","author":"Murtaugh","year":"2012","journal-title":"Nephrology Transplant"},{"key":"10.1016\/j.kint.2017.11.036_bib61","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2215\/CJN.08601209","article-title":"Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients","volume":"5","author":"Noori","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib62","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/ki.2012.303","article-title":"Dietary phosphorus is associated with greater left ventricular mass","volume":"83","author":"Yamamoto","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib63","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib64","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1681\/ASN.2008101106","article-title":"Dietary phosphorus acutely impairs endothelial function","volume":"20","author":"Shuto","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib65","first-page":"1617","article-title":"Deleterious effects of phosphate on vascular and endothelial function via disruption to the nitric oxide pathway","volume":"32","author":"Stevens","year":"2017","journal-title":"Nephrology Transplant"},{"key":"10.1016\/j.kint.2017.11.036_bib66","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2215\/CJN.11181012","article-title":"24\u2013hour urine phosphorus excretion and mortality and cardiovascular events","volume":"8","author":"Palomino","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib67","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/ki.2015.284","article-title":"Relationship of dietary phosphate intake with risk of end-stage renal disease and mortality in chronic kidney disease stages 3-5: the Modification of Diet in Renal Disease study","volume":"89","author":"Selamet","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib68","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.kint.2015.11.006","article-title":"Dietary phosphorus restriction in predialysis chronic kidney disease: time for a cease-fire?","volume":"89","author":"Evenepoel","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib69","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib70","first-page":"CD001892","article-title":"Low protein diets for chronic kidney disease in non diabetic adults","author":"Fouque","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.kint.2017.11.036_bib71","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2337\/diacare.25.4.645","article-title":"Effect of a chicken-based diet on renal function and lipid profile in patients with type 2 diabetes: a randomized crossover trial","volume":"25","author":"Gross","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2017.11.036_bib72","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2008.10.048","article-title":"The effects of dietary patterns on urinary albumin excretion: results of the Dietary Approaches to Stop Hypertension (DASH) trial","volume":"53","author":"Jacobs","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.036_bib73","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ki.1990.178","article-title":"Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins","volume":"38","author":"Kontessis","year":"1990","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib74","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1017\/S1368980009004819","article-title":"Habitual high phosphorus intakes and foods with phosphate additives negatively affect serum parathyroid hormone concentration: a cross-sectional study on healthy premenopausal women","volume":"12","author":"Kemi","year":"2009","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib75","first-page":"480","article-title":"Associations of socioeconomic status and processed food intake with serum phosphorus concentration in community-living adults: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"22","author":"Gutierrez","year":"2012","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib76","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1475-2891-12-94","article-title":"Associations among total and food additive phosphorus intake and carotid intima-media thickness\u2013a cross-sectional study in a middle-aged population in Southern Finland","volume":"12","author":"Itkonen","year":"2013","journal-title":"Nutr J"},{"key":"10.1016\/j.kint.2017.11.036_bib77","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1053\/j.ajkd.2016.08.029","article-title":"Phosphorus additives and albuminuria in early stages of CKD: a randomized controlled trial","volume":"69","author":"Chang","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.036_bib78","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO chronic kidney disease-mineral and bone disorder (CKD-MBD) guideline update: what's changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib79","first-page":"97","article-title":"Replacing phosphorus-containing food additives with foods without additives reduces phosphatemia in end-stage renal disease patients: a randomized clinical trial","volume":"27","author":"de Fornasari","year":"2017","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib80","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2009.96","article-title":"Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial","volume":"301","author":"Sullivan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2017.11.036_bib81","first-page":"476","article-title":"Dietary intervention focused on phosphate intake in hemodialysis patients with hyperphosphoremia","volume":"77","author":"Lou","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib82","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000096410","article-title":"Practical approaches to management of hyperphosphatemia: can we improve the current situation?","volume":"25","author":"Kuhlmann","year":"2007","journal-title":"Blood Purif"},{"key":"10.1016\/j.kint.2017.11.036_bib83","first-page":"285","article-title":"Educational strategies to reduce serum phosphorus in hyperphosphatemic patients with chronic kidney disease: systematic review with meta-analysis","volume":"21","author":"Caldeira","year":"2011","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib84","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1111\/nure.12115","article-title":"Dietary educational interventions for management of hyperphosphatemia in hemodialysis patients: a systematic review and meta-analysis","volume":"72","author":"Karavetian","year":"2014","journal-title":"Nutr Rev"},{"key":"10.1016\/j.kint.2017.11.036_bib85","first-page":"303","article-title":"Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients","volume":"21","author":"Benini","year":"2011","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib86","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1525-139X.2011.00849.x","article-title":"Frequent hemodialysis network trial G. The phosphate binder equivalent dose","volume":"24","author":"Daugirdas","year":"2011","journal-title":"Semin Dial"},{"key":"10.1016\/j.kint.2017.11.036_bib87","first-page":"1","article-title":"Effects of reducing processed culinary ingredients and ultra-processed foods in the Brazilian diet: a cardiovascular modelling study","author":"Moreira","year":"2017","journal-title":"Public Health Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib88","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.3390\/nu7115492","article-title":"Intakes of calcium and phosphorus and calculated calcium-to-phosphorus ratios of older adults: NHANES 2005-2006 data","volume":"7","author":"Adatorwovor","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/j.kint.2017.11.036_bib89","unstructured":"Westenbrink S, Jansen-van der Vliet M. Dutch Food Composition Database: National Institute for Public Health and the Environment (RIVM). Bilthoven, Kingdom of the Netherlands.\u00a02016."},{"key":"10.1016\/j.kint.2017.11.036_bib90","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3945\/ajcn.112.053934","article-title":"Public health impact of dietary phosphorus excess on bone and cardiovascular health in the general population","volume":"98","author":"Calvo","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib91","first-page":"416","article-title":"Differences among total and in\u00a0vitro digestible phosphorus content of plant foods and beverages","volume":"22","author":"Karp","year":"2012","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib92","first-page":"13","article-title":"Contribution of food additives to sodium and phosphorus content of diets rich in processed foods","volume":"24","author":"Carrigan","year":"2014","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib93","doi-asserted-by":"crossref","first-page":"14486","DOI":"10.1074\/jbc.M110.116004","article-title":"Regulation of bile acid synthesis by fat-soluble vitamins A and D","volume":"285","author":"Schmidt","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.kint.2017.11.036_bib94","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.3177\/jnsv.36.4-SupplementI_S25","article-title":"Cooking losses of minerals in foods and its nutritional significance","volume":"36 Suppl 1","author":"Kimura","year":"1990","journal-title":"J\u00a0Nutr Sci Vitaminol (Tokyo)"},{"key":"10.1016\/j.kint.2017.11.036_bib95","first-page":"90","article-title":"Demineralization of a wide variety of foods for the renal patient","volume":"11","author":"Jones","year":"2001","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib96","first-page":"91","article-title":"Phosphate-containing prescription medications contribute to the daily phosphate intake in a third of hemodialysis patients","volume":"27","author":"Nelson","year":"2017","journal-title":"J\u00a0Ren Nutr"},{"key":"10.1016\/j.kint.2017.11.036_bib97","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/ki.2015.67","article-title":"A\u00a0dearth of data: the problem of phosphorus in prescription medications","volume":"87","author":"Sherman","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib98","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD","volume":"23","author":"Block","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib99","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1681\/ASN.2012060569","article-title":"Phosphate binders in CKD: bad news or good news?","volume":"23","author":"Drueke","year":"2012","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib100","doi-asserted-by":"crossref","first-page":"e0156891","DOI":"10.1371\/journal.pone.0156891","article-title":"Comparative effectiveness of phosphate binders in patients with chronic kidney disease: a systematic review and network meta-analysis","volume":"11","author":"Sekercioglu","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2017.11.036_bib101","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/sj.ki.5002518","article-title":"The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer","volume":"72","author":"Russo","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib102","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.03820411","article-title":"Mortality in kidney disease patients treated with phosphate binders: a randomized study","volume":"7","author":"Di Iorio","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib103","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12882-017-0560-3","article-title":"Phosphate binders affect vitamin K concentration by undesired binding, an in\u00a0vitro study","volume":"18","author":"Neradova","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib104","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMra0912522","article-title":"Oral phosphate binders in patients with kidney failure","volume":"362","author":"Tonelli","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.036_bib105","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/j.ajkd.2014.04.014","article-title":"Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D","volume":"64","author":"Yusuf","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.036_bib106","doi-asserted-by":"crossref","first-page":"e0144119","DOI":"10.1371\/journal.pone.0144119","article-title":"Nonadherence to medication therapy in haemodialysis patients: a systematic review","volume":"10","author":"Ghimire","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2017.11.036_bib107","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns study (DOPPS)","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.036_bib108","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/ndt\/gfv099","article-title":"Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study","volume":"30","author":"Fernandez-Martin","year":"2015","journal-title":"Nephrology Transplant"},{"key":"10.1016\/j.kint.2017.11.036_bib109","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.ajkd.2011.12.025","article-title":"Phosphate binder use and mortality among hemodialysis patients in the Dialysis Outcomes and Practice Patterns study (DOPPS): evaluation of possible confounding by nutritional status","volume":"60","author":"Lopes","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.036_bib110","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/ki.2013.185","article-title":"Use of phosphate-binding agents is associated with a lower risk of mortality","volume":"84","author":"Cannata-Andia","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib111","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1681\/ASN.2008060609","article-title":"Phosphorus binders and survival on hemodialysis","volume":"20","author":"Isakova","year":"2009","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib112","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1056\/NEJMoa1205624","article-title":"Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis","volume":"367","author":"Investigators","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.kint.2017.11.036_bib113","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ckj\/sft026","article-title":"Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction","volume":"6","author":"Zitt","year":"2013","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2017.11.036_bib114","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5414\/CN108629","article-title":"Co-trending of parathyroid hormone and phosphate in patients receiving hemodialysis","volume":"85","author":"Block","year":"2016","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib115","doi-asserted-by":"crossref","first-page":"F1466","DOI":"10.1152\/ajprenal.00279.2009","article-title":"Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate","volume":"297","author":"Giral","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2017.11.036_bib116","doi-asserted-by":"crossref","first-page":"C487","DOI":"10.1152\/ajpcell.00412.2001","article-title":"Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)(2) vitamin D(3)","volume":"282","author":"Xu","year":"2002","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.kint.2017.11.036_bib117","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/ndt\/gfh781","article-title":"Nicotinamide prevents the development of hyperphosphataemia by suppressing intestinal sodium-dependent phosphate transporter in rats with adenine-induced renal failure","volume":"20","author":"Eto","year":"2005","journal-title":"Nephrology Transplant"},{"key":"10.1016\/j.kint.2017.11.036_bib118","first-page":"870","article-title":"Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study","volume":"32","author":"Lenglet","year":"2016","journal-title":"Nephrology Transplant"},{"key":"10.1016\/j.kint.2017.11.036_bib119","first-page":"165","article-title":"Use of nicotinamide to treat hyperphosphatemia in dialysis patients","volume":"13","author":"Lenglet","year":"2013","journal-title":"Drugs R\u00a0D"},{"key":"10.1016\/j.kint.2017.11.036_bib120","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.04211007","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients","volume":"3","author":"Cheng","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib121","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4103\/0971-4065.98751","article-title":"The effect of niacin on serum phosphorus levels in dialysis patients","volume":"22","author":"Edalat-Nejad","year":"2012","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib122","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1681\/ASN.2016080855","article-title":"Effect of tenapanor on serum phosphate in patients receiving hemodialysis","volume":"28","author":"Block","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib123","first-page":"S1","article-title":"Kidney disease: improving global outcomes CKDMBDWG. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.kint.2017.11.036_bib124","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/j.ajkd.2013.03.023","article-title":"Sevelamer versus calcium carbonate in incident hemodialysis patients: results of an open-label 24-month randomized clinical trial","volume":"62","author":"Di Iorio","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.036_bib125","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1046\/j.1523-1755.2000.00062.x","article-title":"QTc dispersion increases during hemodialysis with low-calcium dialysate","volume":"57","author":"Nappi","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib126","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2215\/CJN.10000912","article-title":"Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients","volume":"8","author":"Pun","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib127","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2215\/CJN.06800615","article-title":"Sevelamer versus calcium-based binders for treatment of hyperphosphatemia in CKD: a meta-analysis of randomized controlled trials","volume":"11","author":"Patel","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2017.11.036_bib128","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(13)60897-1","article-title":"Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysis","volume":"382","author":"Jamal","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2017.11.036_bib129","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2017.11.036_bib130","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1053\/j.ajkd.2008.02.298","article-title":"A\u00a01-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study","volume":"51","author":"Qunibi","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2017.11.036_bib131","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1093\/ndt\/gfn393","article-title":"Calcium-containing phosphate binders in dialysis patients with cardiovascular calcifications: should we CARE-2 avoid them?","volume":"23","author":"Floege","year":"2008","journal-title":"Nephrol Transplant"},{"key":"10.1016\/j.kint.2017.11.036_bib132","doi-asserted-by":"crossref","first-page":"965","DOI":"10.2215\/CJN.10941016","article-title":"Two phosphAte taRGets in End-stage renal disease Trial (TARGET): a randomized controlled trial","volume":"12","author":"Wald","year":"2017","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818301248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253818301248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T19:29:59Z","timestamp":1751484599000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253818301248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":132,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0085253818301248"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2017.11.036","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention and treatment of hyperphosphatemia in chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2017.11.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}